Summary of Study ST002453
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001580. The data can be accessed directly via it's Project DOI: 10.21228/M8G711 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002453 |
Study Title | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 3 of 3) |
Study Summary | The E4 allele of Apolipoprotein E (APOE) is associated with both metabolic dysfunction and a heightened pro-inflammatory response – two findings that may be intrinsically linked through the concept of immunometabolism. Here, we combined bulk, single-cell, and spatial transcriptomics with cell-specific and spatially resolved metabolic analyses to systematically address the role of APOE across age, neuroinflammation, and AD pathology. RNAseq highlighted immunometabolic changes across the APOE4 glial transcriptome, specifically in subsets of metabolically distinct microglia enriched in the E4 brain during aging or following an inflammatory challenge. E4 microglia display increased Hif1α expression, a disrupted TCA cycle, and are inherently pro-glycolytic, while spatial transcriptomics and MALDI mass spectrometry imaging highlight an E4-specific response to amyloid that is characterized by widespread alterations in lipid metabolism. Taken together, our findings emphasize a central role for APOE in regulating microglial immunometabolism. |
Institute | University of Kentucky |
Department | Physiology |
Laboratory | Lance Johnson; Josh Morganti |
Last Name | Devanney |
First Name | Nicholas |
Address | Physiology, 760 Press Ave, Healthy Kentucky Research Bldg, Rm152, Lexington, Kentucky, 40508, USA |
Nicholas.Devanney@uky.edu | |
Phone | 8593238083 |
Submit Date | 2022-11-14 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Waters) |
Analysis Type Detail | MALDI-MS |
Release Date | 2023-01-25 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001580 |
Project DOI: | doi: 10.21228/M8G711 |
Project Title: | APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge |
Project Summary: | The E4 allele of Apolipoprotein E (APOE) is associated with both metabolic dysfunction and a heightened pro-inflammatory response – two findings that may be intrinsically linked through the concept of immunometabolism. Here, we combined bulk, single-cell, and spatial transcriptomics with cell-specific and spatially resolved metabolic analyses to systematically address the role of APOE across age, neuroinflammation, and AD pathology. RNAseq highlighted immunometabolic changes across the APOE4 glial transcriptome, specifically in subsets of metabolically distinct microglia enriched in the E4 brain during aging or following an inflammatory challenge. E4 microglia display increased Hif1α expression, a disrupted TCA cycle, and are inherently pro-glycolytic, while spatial transcriptomics and MALDI mass spectrometry imaging highlight an E4-specific response to amyloid that is characterized by widespread alterations in lipid metabolism. Taken together, our findings emphasize a central role for APOE in regulating microglial immunometabolism. |
Institute: | University of Kentucky, Department of Physiology |
Last Name: | Devanney |
First Name: | Nicholas |
Address: | Physiology, 760 Press Ave, Healthy Kentucky Research Bldg, Rm152, Lexington, Kentucky, 40508, USA |
Email: | Nicholas.Devanney@uky.edu |
Phone: | 8593238083 |
Project Comments: | Part 2 of 3 |
Subject:
Subject ID: | SU002542 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Genotype Strain: | APOE-targeted replacement mice homozygous for human E3 (B6.129P2-Apoe^tm2(APOE*3)Mae N8, Taconic #1548-F) or human E4 (B6.129P2- Apoe^tm3(APOE*4)Mae N8, Taconic #1549-F) alleles and crossed to the 5x Familial Alzheimer's Disease (5XFAD) model (MMRRC #34840, B6SJL^Tg( APPSwFlLon,PSEN1*M146L*L286V)6799Vas/Mmjax)) |
Age Or Age Range: | 3 months, 12 months, 24 months |
Gender: | Female |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Brain Region | Group | APOE genotype | 5XFAD Genotype | Age |
---|---|---|---|---|---|---|
SA245312 | JJ3_73_Cerebral Nuclei | Cerebral Nuclei | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245313 | JJ3_76_Cerebral Nuclei | Cerebral Nuclei | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245314 | JJ3_66_Cerebral Nuclei | Cerebral Nuclei | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245315 | B427_Cerebral Nuclei | Cerebral Nuclei | E3_old | E3/E3 | Wild-type | 24 months |
SA245316 | B354_Cerebral Nuclei | Cerebral Nuclei | E3_old | E3/E3 | Wild-type | 24 months |
SA245317 | B425_Cerebral Nuclei | Cerebral Nuclei | E3_old | E3/E3 | Wild-type | 24 months |
SA245318 | B647_Cerebral Nuclei | Cerebral Nuclei | E3_young | E3/E3 | Wild-type | 3 months |
SA245319 | B648_Cerebral Nuclei | Cerebral Nuclei | E3_young | E3/E3 | Wild-type | 3 months |
SA245320 | B652_Cerebral Nuclei | Cerebral Nuclei | E3_young | E3/E3 | Wild-type | 3 months |
SA245321 | KK4_116_Cerebral Nuclei | Cerebral Nuclei | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245322 | KK4_96_Cerebral Nuclei | Cerebral Nuclei | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245323 | KK4_40_Cerebral Nuclei | Cerebral Nuclei | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245324 | C202_Cerebral Nuclei | Cerebral Nuclei | E4_old | E4/E4 | Wild-type | 24 months |
SA245325 | C384_Cerebral Nuclei | Cerebral Nuclei | E4_old | E4/E4 | Wild-type | 24 months |
SA245326 | C362_Cerebral Nuclei | Cerebral Nuclei | E4_old | E4/E4 | Wild-type | 24 months |
SA245327 | C763_Cerebral Nuclei | Cerebral Nuclei | E4_young | E4/E4 | Wild-type | 3 months |
SA245328 | C762_Cerebral Nuclei | Cerebral Nuclei | E4_young | E4/E4 | Wild-type | 3 months |
SA245329 | C761_Cerebral Nuclei | Cerebral Nuclei | E4_young | E4/E4 | Wild-type | 3 months |
SA245330 | JJ3_73_Cortical Subplate | Cortical Subplate | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245331 | JJ3_76_Cortical Subplate | Cortical Subplate | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245332 | JJ3_66_Cortical Subplate | Cortical Subplate | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245333 | B425_Cortical Subplate | Cortical Subplate | E3_old | E3/E3 | Wild-type | 24 months |
SA245334 | B354_Cortical Subplate | Cortical Subplate | E3_old | E3/E3 | Wild-type | 24 months |
SA245335 | B427_Cortical Subplate | Cortical Subplate | E3_old | E3/E3 | Wild-type | 24 months |
SA245336 | B647_Cortical Subplate | Cortical Subplate | E3_young | E3/E3 | Wild-type | 3 months |
SA245337 | B648_Cortical Subplate | Cortical Subplate | E3_young | E3/E3 | Wild-type | 3 months |
SA245338 | B652_Cortical Subplate | Cortical Subplate | E3_young | E3/E3 | Wild-type | 3 months |
SA245339 | KK4_96_Cortical Subplate | Cortical Subplate | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245340 | KK4_116_Cortical Subplate | Cortical Subplate | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245341 | KK4_40_Cortical Subplate | Cortical Subplate | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245342 | C202_Cortical Subplate | Cortical Subplate | E4_old | E4/E4 | Wild-type | 24 months |
SA245343 | C362_Cortical Subplate | Cortical Subplate | E4_old | E4/E4 | Wild-type | 24 months |
SA245344 | C384_Cortical Subplate | Cortical Subplate | E4_old | E4/E4 | Wild-type | 24 months |
SA245345 | C763_Cortical Subplate | Cortical Subplate | E4_young | E4/E4 | Wild-type | 3 months |
SA245346 | C762_Cortical Subplate | Cortical Subplate | E4_young | E4/E4 | Wild-type | 3 months |
SA245347 | C761_Cortical Subplate | Cortical Subplate | E4_young | E4/E4 | Wild-type | 3 months |
SA245348 | JJ3_66_Fiber Tracts | Fiber Tracts | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245349 | JJ3_73_Fiber Tracts | Fiber Tracts | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245350 | JJ3_76_Fiber Tracts | Fiber Tracts | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245351 | B427_Fiber Tracts | Fiber Tracts | E3_old | E3/E3 | Wild-type | 24 months |
SA245352 | B425_Fiber Tracts | Fiber Tracts | E3_old | E3/E3 | Wild-type | 24 months |
SA245353 | B354_Fiber Tracts | Fiber Tracts | E3_old | E3/E3 | Wild-type | 24 months |
SA245354 | B648_Fiber Tracts | Fiber Tracts | E3_young | E3/E3 | Wild-type | 3 months |
SA245355 | B647_Fiber Tracts | Fiber Tracts | E3_young | E3/E3 | Wild-type | 3 months |
SA245356 | B652_Fiber Tracts | Fiber Tracts | E3_young | E3/E3 | Wild-type | 3 months |
SA245357 | KK4_40_Fiber Tracts | Fiber Tracts | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245358 | KK4_116_Fiber Tracts | Fiber Tracts | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245359 | KK4_96_Fiber Tracts | Fiber Tracts | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245360 | C384_Fiber Tracts | Fiber Tracts | E4_old | E4/E4 | Wild-type | 24 months |
SA245361 | C202_Fiber Tracts | Fiber Tracts | E4_old | E4/E4 | Wild-type | 24 months |
SA245362 | C362_Fiber Tracts | Fiber Tracts | E4_old | E4/E4 | Wild-type | 24 months |
SA245363 | C762_Fiber Tracts | Fiber Tracts | E4_young | E4/E4 | Wild-type | 3 months |
SA245364 | C763_Fiber Tracts | Fiber Tracts | E4_young | E4/E4 | Wild-type | 3 months |
SA245365 | C761_Fiber Tracts | Fiber Tracts | E4_young | E4/E4 | Wild-type | 3 months |
SA245366 | JJ3_66_Hippocampus | Hippocampus | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245367 | JJ3_73_Hippocampus | Hippocampus | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245368 | JJ3_76_Hippocampus | Hippocampus | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245369 | B425_Hippocampus | Hippocampus | E3_old | E3/E3 | Wild-type | 24 months |
SA245370 | B354_Hippocampus | Hippocampus | E3_old | E3/E3 | Wild-type | 24 months |
SA245371 | B427_Hippocampus | Hippocampus | E3_old | E3/E3 | Wild-type | 24 months |
SA245372 | B652_Hippocampus | Hippocampus | E3_young | E3/E3 | Wild-type | 3 months |
SA245373 | B647_Hippocampus | Hippocampus | E3_young | E3/E3 | Wild-type | 3 months |
SA245374 | B648_Hippocampus | Hippocampus | E3_young | E3/E3 | Wild-type | 3 months |
SA245375 | KK4_116_Hippocampus | Hippocampus | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245376 | KK4_96_Hippocampus | Hippocampus | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245377 | KK4_40_Hippocampus | Hippocampus | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245378 | C384_Hippocampus | Hippocampus | E4_old | E4/E4 | Wild-type | 24 months |
SA245379 | C202_Hippocampus | Hippocampus | E4_old | E4/E4 | Wild-type | 24 months |
SA245380 | C362_Hippocampus | Hippocampus | E4_old | E4/E4 | Wild-type | 24 months |
SA245381 | C761_Hippocampus | Hippocampus | E4_young | E4/E4 | Wild-type | 3 months |
SA245382 | C762_Hippocampus | Hippocampus | E4_young | E4/E4 | Wild-type | 3 months |
SA245383 | C763_Hippocampus | Hippocampus | E4_young | E4/E4 | Wild-type | 3 months |
SA245384 | JJ3_76_Hypothalamus | Hypothalamus | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245385 | JJ3_73_Hypothalamus | Hypothalamus | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245386 | JJ3_66_Hypothalamus | Hypothalamus | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245387 | B425_Hypothalamus | Hypothalamus | E3_old | E3/E3 | Wild-type | 24 months |
SA245388 | B354_Hypothalamus | Hypothalamus | E3_old | E3/E3 | Wild-type | 24 months |
SA245389 | B427_Hypothalamus | Hypothalamus | E3_old | E3/E3 | Wild-type | 24 months |
SA245390 | B647_Hypothalamus | Hypothalamus | E3_young | E3/E3 | Wild-type | 3 months |
SA245391 | B648_Hypothalamus | Hypothalamus | E3_young | E3/E3 | Wild-type | 3 months |
SA245392 | B652_Hypothalamus | Hypothalamus | E3_young | E3/E3 | Wild-type | 3 months |
SA245393 | KK4_116_Hypothalamus | Hypothalamus | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245394 | KK4_96_Hypothalamus | Hypothalamus | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245395 | KK4_40_Hypothalamus | Hypothalamus | E4_FAD | E4/E4 | Hemizygous | 12 months |
SA245396 | C384_Hypothalamus | Hypothalamus | E4_old | E4/E4 | Wild-type | 24 months |
SA245397 | C202_Hypothalamus | Hypothalamus | E4_old | E4/E4 | Wild-type | 24 months |
SA245398 | C362_Hypothalamus | Hypothalamus | E4_old | E4/E4 | Wild-type | 24 months |
SA245399 | C763_Hypothalamus | Hypothalamus | E4_young | E4/E4 | Wild-type | 3 months |
SA245400 | C761_Hypothalamus | Hypothalamus | E4_young | E4/E4 | Wild-type | 3 months |
SA245401 | C762_Hypothalamus | Hypothalamus | E4_young | E4/E4 | Wild-type | 3 months |
SA245402 | JJ3_73_Iso Cortex | Iso Cortex | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245403 | JJ3_76_Iso Cortex | Iso Cortex | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245404 | JJ3_66_Iso Cortex | Iso Cortex | E3_FAD | E3/E3 | Hemizygous | 12 months |
SA245405 | B427_Iso Cortex | Iso Cortex | E3_old | E3/E3 | Wild-type | 24 months |
SA245406 | B425_Iso Cortex | Iso Cortex | E3_old | E3/E3 | Wild-type | 24 months |
SA245407 | B354_Iso Cortex | Iso Cortex | E3_old | E3/E3 | Wild-type | 24 months |
SA245408 | B647_Iso Cortex | Iso Cortex | E3_young | E3/E3 | Wild-type | 3 months |
SA245409 | B652_Iso Cortex | Iso Cortex | E3_young | E3/E3 | Wild-type | 3 months |
SA245410 | B648_Iso Cortex | Iso Cortex | E3_young | E3/E3 | Wild-type | 3 months |
SA245411 | KK4_96_Iso Cortex | Iso Cortex | E4_FAD | E4/E4 | Hemizygous | 12 months |
Collection:
Collection ID: | CO002535 |
Collection Summary: | Three different mice for each experimental group (18 mice in total) were anesthetized via 5.0% isoflurane before exsanguination and transcardial perfusion with ice-cold Dulbecco’s phosphate buffered saline (DPBS; Gibco # 14040133). Following perfusion, hemibrains were quickly removed, leaving behind brainstem and cerebellum. Hemibrains were immediately placed in OCT compound (Fisher HealthCare Tissue Plus O.C.T. Compound Clear 4585) and gently lowered into isopentane (Sigma-Aldrich 2- Methylbutane M32631) in a beaker surrounded by dry ice (isopentane chilled to approximately -70°C). Hemibrains were submerged for 60 seconds, placed on dry ice, wrapped in aluminum foil, and stored at -80°C until sectioning. |
Sample Type: | Brain |
Treatment:
Treatment ID: | TR002554 |
Treatment Summary: | All mice were group housed in sterile micro-isolator cages (Lab Products, Maywood, NJ), and fed autoclaved food and acidified water ad libitum. No additional treatment was applied, with the only comparisons being across different genotypes and ages as specified in the study design table. |
Sample Preparation:
Sampleprep ID: | SP002548 |
Sampleprep Summary: | Prepared brain hemispheres were cryosectioned to 10 μm thick coronal sections at approximately Bregma -2.00 mm. Brain sections were mounted on glass slides and prepared for MALDI MSI as follows: After desiccation for one hour, slides were sprayed with 14 passes of 7mg/mL N-(1-Naphthyl) ethylenediamine dihydrochloride (NEDC) matrix (Sigma) in 70% methanol (HPLC-grade, Sigma) which was applied at 0.06mL/min with a 3mm offset and a velocity of 1200mm/min at 30°C and 10psi using the M5 Sprayer with a heated tray of 50°C. Slides were used immediately or stored in a desiccator until analysis. |
Combined analysis:
Analysis ID | AN004002 |
---|---|
Analysis type | MS |
Chromatography type | None (Direct infusion) |
Chromatography system | none |
Column | none |
MS Type | MALDI |
MS instrument type | QTOF |
MS instrument name | Waters Synapt G2 XS |
Ion Mode | NEGATIVE |
Units | Intensity per pixel |
Chromatography:
Chromatography ID: | CH002955 |
Chromatography Summary: | Not applicable (MALDI MSI) |
Instrument Name: | none |
Column Name: | none |
Column Temperature: | N/A |
Flow Gradient: | N/A |
Flow Rate: | N/A |
Solvent A: | N/A |
Solvent B: | N/A |
Chromatography Type: | None (Direct infusion) |
MS:
MS ID: | MS003750 |
Analysis ID: | AN004002 |
Instrument Name: | Waters Synapt G2 XS |
Instrument Type: | QTOF |
MS Type: | MALDI |
MS Comments: | For the detection of lipids, a Waters SynaptG2-Xs high-definition mass spectrometer equipped with traveling wave ion mobility was employed with the following parameters. The laser was operating at 2000 Hz with an energy of 300 AU and spot size of 50 μm at X and Y coordinates of 100μm with mass range set at 50 – 1000 m/z in negative mode. MALDI-MSI data files were processed to adjust for mass drift during the MALDI scan and to enhance image quality and improve signal-tonoise ratio using an algorithm available within the High-Definition Imaging (HDI) software (Waters Corp). To adjust for mass drift during the MALDI scan, raw files were processed using a carefully curated list of 20 MALDI NEDC matrix peaks (m/z), 26 small molecule MALDI peaks(m/z), and 24 lipid peaks(m/z). Files were processed at a sample duration of 10 sec at a frequency rate of 0.5 min, and an m/z window of 0.1 Da, using an internal lock mass of previously defined metabolite of taurine 124.007 m/z with a tolerance of 1amu and a minimum signal intensity of 100,000 counts. Data acquisition spectrums were uploaded to the HDI software for the generation of lipid images. Regions of interest (ROIs) were user defined by a blinded investigator using anatomical reference points based on the mouse Allen Brain atlas. For all pixels defined within a ROI, peak intensities were averaged and normalized by total ion current (TIC) and number of pixels. |
Ion Mode: | NEGATIVE |